ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.

Federica Pecci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.